Davide Campari-Milano N.V. (BIT: CPR) reports organic net revenue decline year-on-year in the Q3 FY2026 trading update (July–Sept. 2026, release approx. Nov. 6, 2026, confirmed by Campari press release or Bloomberg by Nov. 10, 2026)
Campari faces the same industry headwinds as its peer group: premium spirits de-stocking, weak US on-trade, geopolitically dampened consumer demand. Industry anchor: Brown-Forman reported Q1 FY2027 (July 2026, published Sept. 2, 2026) organic net revenue −1% and flagged a 'challenging' environment. Diageo (open prediction: H1 FY2027 decline) and Pernod Ricard signal similar trends. Campari's flagship Aperol shows European saturation signs; Wild Turkey and Grand Marnier face a weakened US market. No market odds available; analogy estimate ~56%.
56%